Metagen Therapeutics

Tsuruoka, Japan · Founded 2020 · Privately Held (backing)

Operator of microbiome therapeutics and manufacturing platform intended to advance precision treatment using fecal microbiota transplantation. Metagen Therapeutics is based in Tsuruoka, Japan and was founded in 2020. Its last reported valuation was $54.2 million in Jan 2026. It has raised $36.5 million.

Last reported valuation
$54.2M
Oct 2026
Priced at
—
Total raised
$36.5M
Last round
—

Who backs Metagen Therapeutics?

27 investors
InvestorType
Global BrainVenture capital
SMBC Venture CapitalVenture capital
Mizuho CapitalVenture capital
J-StartupOther
JIC Venture Growth InvestmentsVenture capital
Nippon Venture CapitalVenture capital
Mirai Creation CapitalVenture capital
Keio Innovation InitiativeVenture capital
Dentsu VenturesVenture capital
Tokai Tokyo InvestmentOther
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Metagen Therapeutics investors

27 investors are on record for Metagen Therapeutics, including Global Brain, SMBC Venture Capital, Mizuho Capital and J-Startup. By type, the record holds 8 venture capital firms and 1 hedge fund.

Free account
More of Metagen Therapeutics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Metagen Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Metagen Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View